Vaxcyte, Inc. — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2022-12-30

Reporting Person: PICKERING GRANT (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-30	Common Stock	M	15158	$2.03	Acquired	374476	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-30	Stock Option (right to buy)	$47.95	A	108250	Acquired	2032-12-30	Common Stock (108250)	Direct
2022-12-30	Stock Option (right to buy)	$2.03	M	15158	Disposed	2028-07-23	Common Stock (15158)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	157830	Indirect
Common Stock	157830	Indirect

Footnotes

F1: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F2: Shares are held directly by a trust for the benefit of the Reporting Person's son.

F3: 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.

F4: Stock Option is fully vested and exercisable.